Is general anaesthesia preferable to conscious sedation in the treatment of acute ischaemic stroke with intra-arterial mechanical thrombectomy? A review of the literature

[1] Hacke W(1995)Tissue plasminogen activator for acute ischemic stroke N Engl J Med 333 1581-1587

[2] Kaste M(1995)Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: The European Cooperative Acute Stroke Study (ECASS) J Am Med Assoc 274 1017-1025

[3] Fieschi C(1998)Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II): Second European-Australasian Acute Stroke Study Investigators Lancet 352 1245-1511

[4] Hacke W(2008)Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke N Engl J Med 359 1317-1329

[5] Kaste M(2009)Comparison of intravenous alteplase with a combined intravenous-endovascular approach in patients with stroke and confirmed arterial occlusion (RECANALISE study): a prospective cohort study Lancet Neurol 8 802-809

[6] Fieschi C(2004)Improving the predictive accuracy of recanalization on stroke outcome in patients treated with tissue plasminogen activator Stroke 35 151-156

[7] Hacke W(2007)Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke Stroke 38 948-954

[8] Kaste M(1992)Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke Ann Neurol 32 78-86

[9] Bluhmki E(2004)Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study Stroke 35 904-911

[10] Mazighi M(1999)Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial Stroke 30 2598-2605

[1] Hacke W(1995)Tissue plasminogen activator for acute ischemic stroke N Engl J Med 333 1581-1587

[2] Kaste M(1995)Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: The European Cooperative Acute Stroke Study (ECASS) J Am Med Assoc 274 1017-1025

[3] Fieschi C(1998)Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II): Second European-Australasian Acute Stroke Study Investigators Lancet 352 1245-1511

[4] Hacke W(2008)Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke N Engl J Med 359 1317-1329

[5] Kaste M(2009)Comparison of intravenous alteplase with a combined intravenous-endovascular approach in patients with stroke and confirmed arterial occlusion (RECANALISE study): a prospective cohort study Lancet Neurol 8 802-809

[6] Fieschi C(2004)Improving the predictive accuracy of recanalization on stroke outcome in patients treated with tissue plasminogen activator Stroke 35 151-156

[7] Hacke W(2007)Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke Stroke 38 948-954

[8] Kaste M(1992)Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke Ann Neurol 32 78-86

[9] Bluhmki E(2004)Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study Stroke 35 904-911

[10] Mazighi M(1999)Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial Stroke 30 2598-2605